Carcinogenesis Advance Access originally published online on August 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 11, 1811-1817,
November 2003
© 2003 Oxford University Press
CARCINOGENESIS |
Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro
1 National Research Council, 2001 Wisconsin Avenue, NW, Washington DC, 20007 and 2 Human Studies Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA
Telomeres are critical in maintaining chromosome and genomic stability. Arsenic, a human carcinogen as well as an anticancer agent, is known for its clastogenicity. To better understand molecular mechanisms of arsenic actions, we investigated arsenite effects on telomere and telomerase and determined cell growth and apoptosis in HL-60 and HaCaT cells in vitro. Low concentrations (0.1–1 µM in HaCaT and 0.1–0.5 µM in HL-60) of arsenite increased telomerase activity, maintained or elongated telomere length, and promoted cellular proliferation. High concentrations (>1–40 µM) of arsenite decreased telomerase activity, telomere length and induced apoptosis. Results from the studies comparing cell lines with and without telomerase activity suggested that telomerase was involved in arsenic-induced apoptosis. The spin trap agent, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) was effective in protecting the arsenite-induced telomere attrition and apoptosis, suggesting that reactive oxygen species may play an important role in the shortening of telomeres and apoptosis induced by arsenic. These findings suggest the carcinogenic effects of arsenic may be partly attributed to increase in telomerase activity leading to promotion of cell proliferation and its anticancer effects by exerting oxidative stress and leading to telomeric DNA attrition and apoptosis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. MO, Y. XIA, Z. NING, T. J. WADE, and J. L. MUMFORD Elevated ERCC1 Gene Expression in Blood Cells Associated with Exposure to Arsenic from Drinking Water in Inner Mongolia Anticancer Res, August 1, 2009; 29(8): 3253 - 3259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Phatak, F. Dai, M. Butler, M.P. Nandakumar, P. L. Gutierrez, M. J. Edelman, H. Hendriks, and A. M. Burger KML001 Cytotoxic Activity Is Associated with Its Binding to Telomeric Sequences and Telomere Erosion in Prostate Cancer Cells Clin. Cancer Res., July 15, 2008; 14(14): 4593 - 4602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rahman, M. Vahter, E.-C. Ekstrom, M. Rahman, A. H. M. Golam Mustafa, M. A. Wahed, M. Yunus, and L.-A. Persson Association of Arsenic Exposure during Pregnancy with Fetal Loss and Infant Death: A Cohort Study in Bangladesh Am. J. Epidemiol., June 15, 2007; 165(12): 1389 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Poonepalli, L. Balakrishnan, A. K. Khaw, G. K. M. Low, M. Jayapal, R. N. Bhattacharjee, S. Akira, A. S. Balajee, and M. P. Hande Lack of Poly(ADP-Ribose) Polymerase-1 Gene Product Enhances Cellular Sensitivity to Arsenite Cancer Res., December 1, 2005; 65(23): 10977 - 10983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mahata, P. Ghosh, J. N. Sarkar, K. Ray, A. T. Natarajan, and A. K. Giri Effect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water Mutagenesis, May 1, 2004; 19(3): 223 - 229. [Abstract] [Full Text] [PDF]
|
|